Thermo Fisher Scientific plans to sell its diagnostics unit for about $4 billion in an attempt to offload some of its low-growth assets, the Financial Times reported, citing people familiar with the matter. The contract drug manufacturer recently enlisted advisers to explore private equity interest in part of its diagnostics business, including its microbiology unit, which produces infectious disease testing equipment, according to the Financial Times. The auction process does not guarantee a sale, the report said, adding that Thermo Fisher may decide to retain the asset.
Read the full article: Thermo Fisher Plans to Sell Parts of Diagnostics Unit for $4B //
Source: https://finance.yahoo.com/news/thermo-fisher-plans-sell-parts-235359516.html